Biomarker Diagnostics in Periodontal Disease

Periodontal disease is a chronic inflammatory condition that leads to the destruction of supporting tooth structures and ultimately to tooth loss. Traditional diagnosis relies on clinical measurements such as probing depth and bleeding on probing, which detect tissue damage only after it has occurred. Biomarker diagnostics aim to identify molecular signatures of inflammation, tissue degradation and microbial activity in oral fluids—principally saliva and gingival crevicular fluid—enabling earlier detection, risk stratification and monitoring of treatment response. Advances in multiplex immunoassays and point-of-care platforms have made it feasible to quantify panels of cytokines, enzymes and microbial factors within minutes. Integration of predictive models and nomograms further refines individual risk assessment, moving towards personalised periodontal care. The global burden of periodontitis underscores the need for accessible, non-invasive tests that can be deployed in both high-resource and resource-limited settings, with potential to reduce progression, improve patient outcomes and lower long-term healthcare costs.

Research from Nature Portfolio

Recent studies have demonstrated the power of cytokine-based predictive models derived from gingival crevicular fluid to distinguish health, gingivitis and chronic periodontitis. Pro-inflammatory mediators such as interleukin-1α, interleukin-1β and interleukin-17A have been integrated into nomograms alongside interferon-gamma and interleukin-10 to achieve high predictive accuracy adjusted for smoking status. These models translate complex inflammatory profiles into individual probabilities, offering clinicians a decision-support tool for early intervention. Another foundational investigation validated a suite of salivary biomarkers including matrix metalloproteinase-8, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in a well-controlled cohort. The study showed that combining multiple assays and ratio metrics can deliver predictive accuracies exceeding 90%, demonstrating the utility of multiplex approaches and statistical classification trees for personalised monitoring of gingival health and disease progression.

Biomarker Diagnostics in Periodontal Disease publication trend

The graph below shows the total number of articles in biomarker diagnostics in periodontal disease across all publications each year (not limited to Nature Index journals).

Technical terms

Biomarker: A measurable molecule indicating a biological state or disease process.

Cytokine: A small protein released by immune cells to regulate inflammation and tissue response.

Gingival crevicular fluid (GCF): The serum-like fluid found in the sulcus between gum and tooth, rich in biomarkers.

Matrix metalloproteinase (MMP): An enzyme that degrades extracellular matrix components, associated with tissue breakdown.

Nomogram: A graphical tool that integrates multiple variables to estimate the probability of a clinical outcome.

Point-of-care (POC): Diagnostic testing performed near the patient, providing rapid results without central laboratory facilities.

Lab-on-a-chip (LOC): Miniaturised analytical device that integrates multiple laboratory functions on a single microchip.

References

1. Salivary IL-1β, IL-6, and IL-10 Are Key Biomarkers of Periodontitis Severity. International Journal of Molecular Sciences (2024).
2. A Roadmap for the Rational Use of Biomarkers in Oral Disease Screening. Biomolecules (2024).
3. Point-of-care diagnostic devices for periodontitis – current trends and urgent need. Sensors & Diagnostics (2024).
4. Cytokine-based Predictive Models to Estimate the Probability of Chronic Periodontitis: Development of Diagnostic Nomograms. Scientific Reports (2017).
5. Validation and verification of predictive salivary biomarkers for oral health. Scientific Reports (2021).